GlassScriptPhysician profile
Jonah O Ukiwe
NPI 1588644140
$3,692.48
in general payments reported to CMS, 2019-2025
32 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $423 · 2021: $120 · 2022: $1,278 · 2023: $557 · 2024: $77.28 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104 · Education: $69.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.32 |
| Education | $69.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $311.90 | 2019-2023 | Veltassa, Korsuva |
| Amgen INC. | $278.51 | 2019-2025 | Tavneos, Parsabiv |
| Astrazeneca Pharmaceuticals LP | $271.53 | 2019-2025 | Lokelma, Farxiga |
| Novartis Pharmaceuticals Corporation | $244.51 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $238.24 | 2019-2025 | Jynarque |
| Aurinia Pharma U.S., INC. | $215.56 | 2022 | |
| Mallinckrodt Hospital Products INC. | $183.89 | 2020-2022 | |
| Lundbeck LLC | $174.96 | 2019-2020 | |
| Fresenius USA Marketing, INC. | $162.12 | 2022-2025 | Velphoro |
| Bayer Healthcare Pharmaceuticals INC. | $157.59 | 2022-2025 | |
| Akebia Therapeutics INC | $145.15 | 2019-2023 | Auryxia |
| Opko Pharmaceuticals, LLC | $145.00 | 2019-2025 | Rayaldee |
| Mallinckrodt Enterprises LLC | $124.41 | 2019 | |
| Baxter Healthcare | $112.30 | 2019-2022 | |
| Calliditas Therapeutics US INC. | $106.70 | 2022-2025 | Tarpeyo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $100.50 | 2019-2023 | Injectafer |
| Alexion Pharmaceuticals, INC. | $94.52 | 2019-2023 | Ultomiris |
| Ani Pharmaceuticals, INC. | $85.69 | 2022-2023 | Purified Cortrophin Gel |
| Novo Nordisk INC | $84.55 | 2025 | Ozempic, Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $84.35 | 2022-2023 | Gattex |
| Travere Therapeutics, INC. | $72.56 | 2022-2025 | Filspari |
| Medtronic, INC. | $50.38 | 2024 | Symplicity G3 |
| Glaxosmithkline, LLC. | $38.97 | 2023 | Benlysta |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $34.63 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $33.56 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.05 | 2022 | |
| Genentech USA, INC. | $24.22 | 2019 | |
| Genzyme Corporation | $23.64 | 2023 | |
| Horizon Therapeutics Plc | $19.03 | 2020 | |
| Renalytix Ai, INC. | $18.40 | 2022 | |
| Shire North American Group INC | $15.85 | 2019 | |
| Strongbridge US INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonah Ukiwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.